Diseases of the Colon & Rectum

, Volume 50, Issue 1, pp 83–88 | Cite as

Differences in Yeast Intolerance Between Patients with Crohn’s Disease and Ulcerative Colitis

  • Brigitt BrunnerEmail author
  • Ulrich Scheurer
  • Frank Seibold


Alimentary factors, especially those modifying the intestinal flora, may influence the course of inflammatory bowel disease. It is known that T and B cells of patients with Crohn’s disease can be stimulated with the yeast antigen, mannan. We evaluated the impact of eating habits with special respect to food containing yeast on the course of inflammatory bowel disease.


Questionnaires were sent to 180 German-speaking patients of the Inflammatory Bowel Disease Outpatient Clinic at the University Hospital Bern, Switzerland. The following information was obtained by the questionnaires: (1) course of disease, (2) eating habits, (3) environmental data, and (4) inflammatory bowel disease questionnaire. The survey was anonymous.


A total of 145 patients (80.5 percent 95 with Crohn’s disease, and 50 with ulcerative colitis) responded. Food items containing yeast were better tolerated by patients with ulcerative colitis than by patients with Crohn’s disease. A significant difference between the two groups was observed concerning food containing raw yeast (dough, P = 0.04; and pastry, P = 0.001).


Food items containing raw yeast led to more frequent problems for patients with Crohn’s disease than for patients with ulcerative colitis. This observation supports our previous data, which showed the stimulatory effect of the yeast antigen, mannan, on B and T cells of patients with Crohn’s disease but not of controls.

Key words

Crohn’s disease Ulcerative colitis Yeast intolerance Antibodies against the yeast Saccharomyces cerevisiae 


  1. 1.
    Calkins, BM 1989A meta-analysis of the role of smoking in inflammatory bowel diseaseDig Dis Sci3418411854PubMedCrossRefGoogle Scholar
  2. 2.
    Sutherland, LR, Ramcharan, S, Bryant, H, Fick, G 1990Effect of cigarette smoking on recurrence of Crohn’s diseaseGastroenterology9811231128PubMedGoogle Scholar
  3. 3.
    Sutton, CL, Yang, H, Li, Z, Rotter, JI, Targan, SR, Braun, J 2000Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn’s diseaseGut465863PubMedCrossRefGoogle Scholar
  4. 4.
    Vermeire, S, Joossens, S, Peeters, M,  et al. 2001Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel diseaseGastroenterology120827833PubMedCrossRefGoogle Scholar
  5. 5.
    Seibold, F, Stich, O, Hufnagl, R, Kamil, S, Scheurlen, M 2001Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family studyScand J Gastroenterol36196201PubMedCrossRefGoogle Scholar
  6. 6.
    Vermeire, S, Peeters, M, Vlictinck, R,  et al. 2001Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD familiesInflamm Bowel Dis7815PubMedCrossRefGoogle Scholar
  7. 7.
    Peeters, M, Joossens, S, Vermeire, S, Vlietinck, R, Bossuyt, X, Rutgeerts, P 2001Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseaseAm J Gastroenterol96730734PubMedCrossRefGoogle Scholar
  8. 8.
    Annese, V, Andreoli, A, Andriulli, A,  et al. 2001Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn’s disease and ulcerative colitis: aGISC studyAm J Gastroenterol9624072412PubMedCrossRefGoogle Scholar
  9. 9.
    Quinton, JF, Sendid, B, Reumaux, D,  et al. 1998Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic roleGut42788791PubMedCrossRefGoogle Scholar
  10. 10.
    Konrad, A, Rutten, C, Flogerzi, B, Styner, M, Goke, B, Seibold, F 2004Immune sensitization to yeast antigens in ASCA-positive patients with Crohn’s diseaseInflamm Bowel Dis1097105PubMedCrossRefGoogle Scholar
  11. 11.
    Seibold, F, Konrad, A, Flogerzi, B,  et al. 2004Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn’s diseaseGastroenterology12710761084PubMedCrossRefGoogle Scholar
  12. 12.
    Medzhitov, R 2001Toll-like receptors and innate immunityNat Rev Immunol1135145PubMedCrossRefGoogle Scholar
  13. 13.
    Tada, H, Nemoto, E, Shimauchi, H,  et al. 2002Saccharomyces cerevisiae and Candida albicans derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD 14- and Toll-like receptor 4- dependent mannerMicrobiol Immunol46503512PubMedGoogle Scholar
  14. 14.
    Franchimont, D, Vermeire, S, Housni, H,  et al. 2004Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitisGut53987992PubMedCrossRefGoogle Scholar
  15. 15.
    Mitchell, A, Guyatt, G, Singer, J,  et al. 1988Quality of life in patients with inflammatory bowel diseaseJ Clin Gastroenterol10306310PubMedCrossRefGoogle Scholar
  16. 16.
    Guyatt, G, Mitchell, A, Irvine, EJ,  et al. 1989A new measure of health status for clinical trials in inflammatory bowel diseaseGastroenterology96804810PubMedGoogle Scholar
  17. 17.
    Kocourek, J, Ballou, CE 1969Method for fingerprinting yeast cell wall mannansJ Bacteriol10011751181PubMedGoogle Scholar
  18. 18.
    Mayberry, JF, Rhodes, J 1984Epidemiological aspects of Crohn’s disease: a review of literatureGut25886899PubMedGoogle Scholar
  19. 19.
    Calkins, BM, Medeloff, AI 1986Epidemiology of inflammatory bowel diseaseEpidemiol Rev86091PubMedGoogle Scholar
  20. 20.
    Barclay, GR, McKenzie, H, Pennington, J, Parratt, D, Pennington, CR 1992The effect of dietary yeast on the activity of stable chronic Crohn’s diseaseScand J Gastroenterol27196200PubMedGoogle Scholar
  21. 21.
    Vasiliauskas, EA, Kam, LY, Karp, LC, Gaiennie, J, Yang, H, Targan, SR 2000Marker antibody expression stratifies Crohn’s disease into immunologically homogenous subgroups with distinct clinical characteristicsGut47487496PubMedCrossRefGoogle Scholar
  22. 22.
    Walker, LJ, Aldhous, MC, Drummond, HE,  et al. 2004Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn’s disease are associated with disease severity but not NOD2/CARD15 mutationsClin Exp Immunol135490496PubMedCrossRefGoogle Scholar
  23. 23.
    Zholudev, A, Zurakowski, D, Young, W, Leichtner, A, Bousvaros, A 2004Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn’s disease and ulcerative colitis: diagnostic value and correlation with disease phenotypeAm J Gastroenterol9922352241PubMedCrossRefGoogle Scholar

Copyright information

© The American Society of Colon and Rectal Surgeons 2006

Authors and Affiliations

  • Brigitt Brunner
    • 1
    • 2
    Email author
  • Ulrich Scheurer
    • 1
  • Frank Seibold
    • 1
  1. 1.Department of GastroenterologyUniversity of BernBernSwitzerland
  2. 2.Kantonsspital UriAltdorfSwitzerland

Personalised recommendations